Davis Polk advised Bausch Health Companies Inc. in connection with the separation of its eye health business into a new publicly traded company, Bausch + Lomb...
Bausch + Lomb’s $630 Million Initial Public Offering
nCino’s US$1.2 Billion Acquisition of SimpleNexus
Sidley Austin advised nCino on the deal, while Willkie Farr & Gallagher advise SimpleNexus. nCino announced its definitive agreement to acquire SimpleNexus in a stock and cash...
TradeUP Global Corporation’s Merger with SAITECH
Sidley Austin advised TradeUP Global Corporation on the deal, while Winston & Strawn and Harneys represented SAITECH Limited. TradeUP Global Corporation, a publicly traded special purpose...
Tyra Biosciences’ $172.8 Million Initial Public Offering
Latham & Watkins represented Tyra Biosciences in the offering while Sidley advised the underwriters. Tyra Biosciences, Inc. has announced the pricing of its upsized initial public offering of...
Immuneering’s US$129.4 Million IPO
Sidley Austin advised the underwriters on the deal, while Choate and Latham & Watkins assisted Immuneering Corporation. Immuneering Corporation (Nasdaq: IMRX), a biopharmaceutical company advancing a...
Membership Collective Group’s US$420 Million IPO
Sidley Austin LLP advised Membership Collective Group Inc. on the deal, while Davis Polk advised the underwriters. Membership Collective Group (“MCG”), a global membership platform comprised...
Athene Holding’s US$11 Billion Merger With Apollo Global Management
Sidley Austin LLP, Conyers and Walkers Bermuda acted for Athene Holding on the deal. Athene Holding announced its proposed merger with Apollo Global Management, in an all-stock...